Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK

Antiviral Res. 2013 Aug;99(2):139-48. doi: 10.1016/j.antiviral.2013.04.017. Epub 2013 May 4.

Abstract

Human cytomegalovirus infection can lead to life-threatening clinical manifestations particularly in the immunocompromised host. Current therapy options face severe limitations leading to a continued search for alternative drug candidates. Viral replication is dependent on a balanced interaction between viral and cellular proteins. Especially protein kinases are important regulators of virus-host interaction indicated by remarkable kinome alterations induced upon HCMV infection. Here we report a novel approach of kinome profiling with an outcome that suggests an important role of specific cellular protein kinases, such as AMPK, ABL2 and Aurora A. Inhibition of AMPK and ABL kinases showed a significant reduction, whereas inhibition of Aurora A kinase led to a slight activation of HCMV replication, as measured in a GFP reporter-based replication assay. Furthermore, analysis of the mode of antiviral action suggested a substantial benefit for the efficiency of viral replication at the immediate early (AMPK) or early-late (ABL) phases of HCMV gene expression. In contrast, inhibition of Aurora A kinase promoted an enhancement of viral early-late gene expression, suggesting a putative role of Aurora A signaling in host defense. Thus, the combined data provide new information on host cell kinases involved in viral replication and uncovered potential targets for future antiviral strategies.

Keywords: Antiviral targets; Host cell kinome; Human cytomegalovirus; Kinase inhibitors; Mass spectrometry-based profiling; Regulatory protein kinases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / metabolism*
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Aurora Kinase A / antagonists & inhibitors
  • Aurora Kinase A / metabolism*
  • Benzamides / pharmacology
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cytomegalovirus / genetics
  • Cytomegalovirus / physiology*
  • Cytomegalovirus Infections / enzymology*
  • Cytomegalovirus Infections / virology
  • Gene Expression Regulation, Viral / drug effects
  • Humans
  • Imatinib Mesylate
  • Intracellular Signaling Peptides and Proteins
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Nucleic Acid Synthesis Inhibitors / therapeutic use
  • Piperazines / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins c-abl / antagonists & inhibitors
  • Proto-Oncogene Proteins c-abl / metabolism*
  • Pyrimidines / pharmacology
  • Serine-Threonine Kinase 3
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Benzamides
  • Intracellular Signaling Peptides and Proteins
  • Nucleic Acid Synthesis Inhibitors
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • STK4 protein, human
  • Proto-Oncogene Proteins c-abl
  • Aurora Kinase A
  • Protein Serine-Threonine Kinases
  • STK3 protein, human
  • Serine-Threonine Kinase 3
  • ULK3 protein, human
  • AMP-Activated Protein Kinases